Here is an interesting post from the swamp: Rdu
Post# of 72440
Rdunn88 Saturday, 06/30/18 03:02:27 PM
Re: scottsmith post# 232966 0
Post #
232986
of 233044
SS, we've both been highly critical of Leo, but you have to admit the biotech market can reward early stage bio's in a large way. Look at the buyouts of both Kite/Juno Pharma. Their pipelines were no further along when given billion dollar valuations a few years back... The biggest drag for IPIX has been cash, cash and more cash... Leo now has a 90 day window to produce results.
https://www.cnbc.com/2018/01/22/celgene-to-bu...llion.html
http://www.gilead.com/news/press-releases/201...19-billion
Go IPIX!!!